SCoR Talk


Wednesday, May 15, 2019

Deadline approaching for The Wonders of Hybrid Imaging and Molecular Radiotherapy

The deadline for abstract submissions to present a proffered poster at The Wonders of Hybrid Imaging and Molecular Radiotherapy event this autumn is 30 June 2019.

Do you have work on molecular imaging and theranostics that you would like to share with your peers? This is a great opportunity to gain feedback and recognition from your peers.

The Nuclear Medicine and Molecular Imaging Advisory Group (NMMAG) of the SCoR would welcome submission of posters from students, nuclear medicine trainees, clinical radiographers at all tiers, nuclear medicine technologists, service managers, research radiographers, educationalists, and other members of the multi-professional nuclear medicine team, to be presented at the study day on 5 November in London.

Submissions will be accepted within the topic areas of:

  • PET CT
  • Theranostics in prostate cancer, neuroendocrine tumours and thyroid cancer
  • Commissioning of a molecular radionuclide therapy (MRT) service
  • Radiation protection considerations for MRT

All proffered posters must follow a set format and will be anonymously and independently assessed by the NMMAG. Those with the highest marks will be selected for presentation.

Please note that in order to display a poster, authors must register and pay to attend the conference. All accepted poster abstracts will be published in the study day booklet and there will be prizes for the best submissions.

For more information about displaying a poster and to submit your abstract, visit the proffered poster submission webpage.

Registration for the conference is open. To view the provisional programme and fees, visit our event webpage.

Other stories in this issue…

Content tools

Printer-friendly version